subject: PR:000001151

object_name: malignant mesothelioma


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: squamous cell carcinoma

tested_intervention: unsure


subject: PR:000001151

object_name: Stomach cancer


subject: PR:000001151

object_name: gastric cancer


subject: PR:000001151

object_name: pancreatic neoplasm


subject: PR:000001151

object_name: exocrine pancreatic carcinoma


subject: PR:000001151

object_name: malignant pancreatic neoplasm


subject: PR:000001151

object_name: malignant soft tissue neoplasm


subject: PR:000001151

object_name: sarcoma


subject: PR:000001151

object_name: mismatch repair cancer syndrome 1


subject: PR:000001151

object_name: Turcot syndrome


subject: PR:000001151

object_name: Mismatch Repair Deficiency


subject: PR:000001151

object_name: colorectal cancer


subject: PR:000001151

object_name: colorectal carcinoma


subject: PR:000001151

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PR:000001151

object_name: neuroendocrine neoplasm


subject: PR:000001151

object_name: Microsatellite Instability


subject: PR:000001151

object_name: trabecular adenocarcinoma


subject: PR:000001151

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:188074

object_name: Critical Illness


subject: CHEBI:188074

object_name: multiple organ dysfunction syndrome


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: MESH:D019444

subject_name: Vaccines, DNA

object_name: influenza

tested_intervention: yes


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: gestational diabetes


subject: DRUGBANK:DB11357

subject_name: Linseed oil


subject: CHEBI:39585

subject_name: Carbidopa

object_name: neuralgia


subject: CHEBI:39585

object_name: Neuropathic pain


subject: CHEBI:39585

object_name: spinal cord injury


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:3222

object_name: Chagas cardiomyopathy


subject: CHEBI:4784

subject_name: Enalapril


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril


subject: CHEBI:157903

subject_name: Tyr-Cys

object_name: Sedentary lifestyle


subject: CHEBI:33353

subject_name: technetium atom


subject: UMLS:C0040642

subject_name: Transcobalamin


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: proteinuria


subject: CHEBI:89324

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:89324

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:89324

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C4043330

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:6367079

subject_name: Nepicastat

object_name: cocaine dependence


subject: CHEBI:4453

subject_name: Desogestrel

object_name: central sleep apnea syndrome


subject: CHEBI:45716

subject_name: Vorinostat

object_name: small intestine cancer


subject: CHEBI:45716

object_name: small intestine carcinoma


subject: CHEBI:8107

subject_name: Phenytoin

object_name: malignant soft tissue neoplasm


subject: CHEBI:8107

object_name: sarcoma


subject: CHEBI:8107

object_name: Ewing sarcoma


subject: DRUGBANK:DB16564

subject_name: Mucopolysaccharide polysulphate


subject: DRUGBANK:DB16564


subject: DRUGBANK:DB16564


subject: UMLS:C3541972

subject_name: Carbohydrate nutrients

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C3541972

object_name: COPD, severe early onset


subject: UMLS:C3541972

object_name: chronic obstructive pulmonary disease


subject: CHEBI:16646

subject_name: carbohydrate


subject: CHEBI:16646


subject: CHEBI:16646


subject: CHEBI:25017

subject_name: leucine


subject: CHEBI:25017


subject: CHEBI:132922

object_name: Contraceptive IUD removal awaited (finding)


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Tobacco user


subject: CHEBI:66964

object_name: Tobacco use history


subject: CHEBI:66964

object_name: Encounter due to tobacco use


subject: PUBCHEM.COMPOUND:166625366

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:166625366

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:166625366

object_name: Solid Neoplasm


subject: UNII:Q2GM754LLG


subject: UNII:Q2GM754LLG


subject: UNII:Q2GM754LLG


subject: UNII:05HYK3CV9N

subject_name: Linperlisib

object_name: indolent B-cell non-Hodgkin lymphoma


subject: CHEBI:35864

object_name: lung cancer


subject: CHEBI:35864

object_name: lung neoplasm


subject: CHEBI:35864

object_name: lung carcinoma


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Pulmonary artery pressure


subject: CHEBI:17061

object_name: Non-transfusion dependent thalassaemia


subject: CHEBI:30011

subject_name: L-glutamine residue


subject: CHEBI:30011


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: UNII:2P987FW4E8

object_name: Clostridium difficile colitis


subject: UMLS:C4547458


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: HIV infection


subject: CHEBI:2666

object_name: peripheral nervous system disorder


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: poorly differentiated thyroid gland carcinoma


subject: CHEBI:75045

object_name: thyroid gland papillary carcinoma


subject: CHEBI:75045

object_name: thyroid gland follicular carcinoma


subject: CHEBI:75045

object_name: thyroid cancer, nonmedullary, 2


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: Prostate cancer recurrent


subject: UNII:68AYS9A614

object_name: castration-resistant prostate carcinoma


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:190514


subject: CHEBI:49375


subject: UMLS:C3896931

object_name: metastatic colorectal cancer


subject: UMLS:C3896931

object_name: rectal carcinoma


subject: UMLS:C3896931

object_name: rectal cancer


subject: UMLS:C3896931

object_name: Childhood Rectal Carcinoma


subject: UMLS:C3896931

object_name: colon carcinoma


subject: UMLS:C3896931

object_name: colorectal cancer


subject: UMLS:C3896931

object_name: colon cancer


subject: UMLS:C2346878

object_name: Solid Neoplasm


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: hypoalphalipoproteinemia


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: Agitation


subject: CHEBI:4636

object_name: Restlessness


subject: CHEBI:4636

object_name: Restlessness, CTCAE


subject: CHEBI:4636

object_name: Nausea, CTCAE_5


subject: CHEBI:4636

object_name: Nausea


subject: CHEBI:4636

object_name: Nausea, CTCAE_3


subject: CHEBI:5613

subject_name: Haloperidol


subject: CHEBI:5613


subject: UMLS:C0591192

subject_name: Bricanyl

object_name: Acute exacerbation of chronic obstructive pulmonary disease


subject: CHEBI:9449

subject_name: Terbutaline


subject: DRUGBANK:DB17931

subject_name: Engensis

object_name: Diabetic peripheral neuropathy


subject: PUBCHEM.COMPOUND:12443252

subject_name: Tauroursodeoxycholic acid

object_name: chronic progressive multiple sclerosis


subject: CHEBI:80774

subject_name: taurursodiol


subject: UMLS:C2830036


subject: UMLS:C2830036

object_name: colorectal carcinoma


subject: UMLS:C2830036

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3502775

object_name: Advanced Gastric Adenocarcinoma


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib


subject: CHEBI:10033

subject_name: Warfarin

object_name: chronic kidney disease


subject: CHEBI:10033

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Sepsis


subject: CHEBI:51254

object_name: Sepsis, CTCAE


subject: CHEBI:51254

object_name: neonatal sepsis


subject: CHEBI:51254

object_name: Bacterial sepsis of newborn


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: UMLS:C1443088

subject_name: Aesculus hippocastanum antigen

object_name: univentricular heart


subject: UMLS:C1443088

object_name: Single ventricle


subject: UMLS:C4723748

subject_name: Aesculus hippocastanum extract


subject: UMLS:C4723748


subject: UNII:RUU8G67GQM

subject_name: Escin


subject: UNII:RUU8G67GQM


subject: DRUGBANK:DB13195

subject_name: Horse chestnut


subject: DRUGBANK:DB13195


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol

object_name: inflammatory bowel disease


subject: PUBCHEM.COMPOUND:6912

object_name: clostridium difficile infection


subject: CHEBI:17151


subject: CHEBI:17151


subject: UMLS:C2348200

subject_name: Sialyl Lewis-Keyhole Limpet Hemocyanin Conjugate Vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C2348200

object_name: breast carcinoma


subject: UMLS:C2348200

object_name: breast cancer


subject: CHEBI:90942

subject_name: Ixazomib

object_name: genetic disease


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Fibrous corn


subject: CHEBI:7852

subject_name: Oxycodone

object_name: malnutrition


subject: CHEBI:7852

object_name: outcomes general quality of life


subject: CHEBI:7852

object_name: Perceived quality of life


subject: CHEBI:7852

object_name: Good quality of life


subject: CHEBI:35526

subject_name: hypoglycemic agent

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:35526

object_name: metabolic syndrome X


subject: UMLS:C0020616

subject_name: Hypoglycemic Agents


subject: UMLS:C0020616


subject: UMLS:C0966994

object_name: malignant soft tissue neoplasm


subject: UMLS:C0966994

object_name: sarcoma


subject: UMLS:C0966994

object_name: glioma


subject: UMLS:C0966994

object_name: malignant glioma


subject: DRUGBANK:DB15654

subject_name: Moderna COVID-19 Vaccine

object_name: Allergy


subject: DRUGBANK:DB15654

object_name: hypersensitivity reaction disease


subject: DRUGBANK:DB15654

object_name: Allergic Reaction, CTCAE


subject: DRUGBANK:DB15654

object_name: mastocytosis


subject: DRUGBANK:DB15654

object_name: severe acute respiratory syndrome


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran


subject: UNII:JSV288Q5CV


subject: UNII:JSV288Q5CV


subject: UNII:JSV288Q5CV


subject: UNII:JSV288Q5CV


subject: PUBCHEM.COMPOUND:11236066

subject_name: BRIMONIDINE TARTRATE

object_name: presbyopia


subject: UNII:JS88RK5NOI

subject_name: PIREPEMAT

object_name: Parkinson disease


subject: DRUGBANK:DB19165

subject_name: Pirepemat


subject: CHEBI:73788

subject_name: Ala-Gln

object_name: decubitus ulcer


subject: UMLS:C0498903

subject_name: Injection, droperidol, up to 5 mg administered

object_name: digestive system disorder


subject: UMLS:C0498903

object_name: female reproductive system disorder


subject: UMLS:C0498903

object_name: urinary system disorder


subject: UMLS:C2092255

subject_name: Droperidol Liquid Injection


subject: UMLS:C2092255


subject: UMLS:C2092255


subject: CHEBI:4717

subject_name: Droperidol


subject: CHEBI:4717


subject: CHEBI:4717


subject: UMLS:C4721945

subject_name: perflutren, human albumin microspheres

object_name: breast carcinoma


subject: UMLS:C4510275

subject_name: Sulfur hexafluoride lipid microsphere


subject: UMLS:C3485978

subject_name: beta3-Adrenergic Agonist [EPC]

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3485978

object_name: obesity


subject: UMLS:C3485978

object_name: Obesity, CTCAE


subject: CHEBI:2549

subject_name: Albuterol

object_name: Mild asthma


subject: CHEBI:91899


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:72292

subject_name: Bedaquiline


subject: CHEBI:63607

subject_name: Linezolid


subject: UNII:2XOI31YC4N

subject_name: Pretomanid


subject: CHEBI:8863

subject_name: Riluzole

object_name: schizophrenia


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Pelvic mass


subject: UMLS:C3642349

subject_name: Volulyte

object_name: Burn injury


subject: UNII:45X7OU8C4J

subject_name: DOMVANALIMAB

object_name: PD-L1 Overexpression


subject: UNII:45X7OU8C4J

object_name: PD-L1 Positive


subject: UNII:45X7OU8C4J

object_name: triple-negative breast carcinoma


subject: UNII:45X7OU8C4J

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5206853

subject_name: Domvanalimab


subject: UMLS:C5206853


subject: UMLS:C5206853


subject: UMLS:C5206853


subject: UNII:UKI9MLD5OI

subject_name: DOM


subject: UNII:UKI9MLD5OI


subject: UNII:UKI9MLD5OI


subject: UNII:UKI9MLD5OI


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan


subject: PUBCHEM.COMPOUND:156963654


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UNII:5YV419FIJS

subject_name: sodium glycididazole


subject: UNII:5YV419FIJS


subject: CHEBI:74814

subject_name: Ser-Gly


subject: CHEBI:74814


subject: CHEBI:33351

subject_name: seaborgium atom


subject: CHEBI:33351


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C1321801

subject_name: Fiber brand of calcium polycarbophil

object_name: gestational diabetes


subject: UMLS:C0225326

subject_name: fiber


subject: UMLS:C3827168

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:41139

subject_name: BETAINE

object_name: syringomyelia


subject: CHEBI:41139

object_name: Syringomyelia and syringobulbia


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: fibromyalgia


subject: UMLS:C5235868

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108102

subject_name: ST. JOHN'S WORT

object_name: acute coronary syndrome


subject: CHEBI:41423

subject_name: Celecoxib

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:41423

object_name: Childhood Central Nervous System Neoplasm


subject: CHEBI:41423

object_name: leukemia


subject: CHEBI:41423

object_name: childhood leukemia


subject: CHEBI:41423

object_name: adult lymphoma


subject: CHEBI:41423

object_name: lymphoma


subject: CHEBI:41423

object_name: pediatric lymphoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:5001

subject_name: Fenofibrate


subject: CHEBI:5001


subject: CHEBI:5001

object_name: Childhood Neuroblastoma


subject: CHEBI:5001

object_name: neuroblastoma


subject: CHEBI:5001


subject: CHEBI:5001


subject: CHEBI:5001


subject: CHEBI:5001


subject: CHEBI:5001


subject: CHEBI:5001

object_name: malignant soft tissue neoplasm


subject: CHEBI:5001

object_name: sarcoma


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Acute on chronic hepatic failure


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:176724

subject_name: Etiracetam

object_name: generalized epilepsy


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: PUBCHEM.COMPOUND:160883

subject_name: Butylscopolamine

object_name: Vaginal delivery (finding)


subject: PUBCHEM.COMPOUND:160883

object_name: previous vaginal delivery (history)


subject: UNII:U8736VCB22

subject_name: Letrazuril

object_name: HIV infection


subject: UNII:U8736VCB22

object_name: cryptosporidiosis


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: systemic sclerosis


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Intolerance to drug


subject: CHEBI:93775

subject_name: Amethopterin

object_name: anterolateral myocardial infarction


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:59594

subject_name: Colesevelam

object_name: irritable bowel syndrome


subject: CHEBI:6801

subject_name: Metformin

object_name: thyroid gland carcinoma


subject: CHEBI:6801

object_name: thyroid cancer


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: Critical Illness


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:6970

subject_name: Mometasone

object_name: Early radiation dermatitis


subject: UMLS:C4045914

object_name: type 2 diabetes mellitus


subject: CHEBI:6801

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:6801

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C5399992

object_name: Refractory High Risk Myelodysplastic Syndrome


subject: UMLS:C5399992

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UMLS:C5399992

object_name: High Risk Chronic Myelomonocytic Leukemia


subject: UMLS:C5399992

object_name: Recurrent High Risk Myelodysplastic Syndrome


subject: UMLS:C5399992

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: UMLS:C5399992

object_name: Blasts More than 5 Percent of Bone Marrow Nucleated Cells


subject: UMLS:C5399992

object_name: Blasts 10-19 Percent of Bone Marrow Nucleated Cells


subject: UMLS:C0445115

subject_name: Normal saline

object_name: intracranial hypertension


subject: CHEBI:31355

subject_name: Carboplatin

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:135810

subject_name: Atrasentan

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:135810

object_name: Embolism, Tumor


subject: CHEBI:135810

object_name: Neoplasm Metastasis


subject: UMLS:C1765313

subject_name: Atrasentan Hydrochloride


subject: UMLS:C1765313


subject: UMLS:C1765313


subject: CHEBI:95165

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:91512

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:91512

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:91512

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:91512

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:91512

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:91512

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:91512

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:91512

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:91512

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:91512


subject: CHEBI:91512

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:91512

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:91512

object_name: adult acute monocytic leukemia


subject: CHEBI:91512

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:91512

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:91512

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:91512

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: CHEBI:71019

subject_name: omacetaxine

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:71019

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:71019

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:71019

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:71019

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:71019

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:71019

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:71019

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:71019

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:71019


subject: CHEBI:71019

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:71019

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:71019

object_name: adult acute monocytic leukemia


subject: CHEBI:71019

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:71019

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:71019

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:71019

object_name: Adult Erythroleukemia


subject: UMLS:C5446373

subject_name: CDK2 Inhibitor PF-07104091

object_name: Solid Neoplasm


subject: UMLS:C5446887

subject_name: CDK4 Inhibitor PF-07220060


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: thyroid disease


subject: PUBCHEM.COMPOUND:5281767

object_name: Hashimoto thyroiditis


subject: PUBCHEM.COMPOUND:5281767

object_name: hypothyroidism


subject: PUBCHEM.COMPOUND:5281767

object_name: Hypothyroidism, CTCAE


subject: CHEBI:91951

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: UMLS:C3660928


subject: CHEBI:6413

subject_name: Letrozole


subject: UMLS:C5139953

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5139953

object_name: obesity


subject: UMLS:C5139953

object_name: Obesity, CTCAE


subject: UMLS:C5139821

subject_name: Efinopegdutide


subject: UMLS:C5139821


subject: UMLS:C5139821


subject: CHEBI:49140

object_name: cardiovascular disorder


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Frailty


subject: CHEBI:15927

object_name: Frail elderly syndrome


subject: CHEBI:15927

object_name: Frailty Syndrome


subject: CHEBI:145751

subject_name: Asn-Arg


subject: CHEBI:145751


subject: CHEBI:145751


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: myeloproliferative neoplasm


subject: CHEBI:141969

object_name: adult lymphoma


subject: CHEBI:141969

object_name: lymphoma


subject: CHEBI:141969

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: UNII:MA05AF40UO

subject_name: PIMIVALIMAB

object_name: non-small cell lung carcinoma


subject: UMLS:C4763652

subject_name: Pimivalimab


subject: CHEMBL.COMPOUND:CHEMBL4298004

subject_name: VOPRATELIMAB


subject: UMLS:C4329331

subject_name: Vopratelimab


subject: CHEBI:3566

subject_name: cetylpyridinium chloride monohydrate

object_name: gingivitis


subject: CHEBI:165822

subject_name: CpC


subject: PUBCHEM.COMPOUND:54675873


subject: UMLS:C5959582

subject_name: Chromosomal Passenger Complex


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Drug Interactions


subject: UMLS:C1176021

object_name: Plexosarcoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:231614

object_name: Refractory Pancreatic Adenocarcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2348637

subject_name: TLR9 Agonist SD-101


subject: UMLS:C2348637


subject: UMLS:C2348637

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:90942

subject_name: Ixazomib

object_name: follicular lymphoma


subject: CHEBI:90942

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:90942

object_name: marginal zone lymphoma


subject: CHEBI:90942

object_name: MALT lymphoma


subject: CHEBI:90942

object_name: lymphoplasmacytic lymphoma


subject: CHEBI:90942

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) recurrent


subject: CHEBI:90942

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) refractory


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C4706114

object_name: osteoarthritis, knee


subject: UMLS:C2045803

subject_name: chemotherapeutic combinations

object_name: Advanced Melanoma


subject: CHEBI:47657

subject_name: Roflumilast

object_name: B-cell neoplasm


subject: MESH:C000613845

subject_name: fermented papaya preparation

object_name: end stage renal failure


subject: MESH:C000613845

object_name: anemia


subject: MESH:C000613845

object_name: Anemia, CTCAE


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: paroxysmal atrial fibrillation


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: persian gulf syndrome


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: esophagitis


subject: UNII:2P471X1Z11

object_name: Esophagitis, CTCAE


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Hot Flashes, CTCAE


subject: CHEBI:63611

object_name: Hot flashes


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Supraventricular Tachycardia by ECG Finding


subject: CHEBI:4466

object_name: Supraventricular tachycardia


subject: CHEBI:4466

object_name: Supraventricular Tachycardia, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UMLS:C0678021

subject_name: Ad5CMV-p53 gene

object_name: liver cancer


subject: UMLS:C0678021

object_name: liver neoplasm


subject: UMLS:C0678021

object_name: Adult Liver Carcinoma


subject: UMLS:C0678021

object_name: liver carcinoma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: clear cell renal carcinoma


subject: UMLS:C0013227

object_name: Clear-cell metastatic renal cell carcinoma


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: Infection of transplanted kidney


subject: MESH:D000086663

object_name: severe acute respiratory syndrome


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5400806


subject: UMLS:C4033631

subject_name: sacubitril / valsartan

object_name: hypertension


subject: UMLS:C4033631

object_name: Hypertension, CTCAE


subject: UMLS:C4033631

object_name: Recurrent atrial fibrillation


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Refractory Medulloblastoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Primitive Neuroectodermal Tumor


subject: UNII:2S9ZZM9Q9V

object_name: Adult Central Nervous System Neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: central nervous system neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Peripheral Primitive Neuroectodermal Tumor


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Pineoblastoma


subject: UNII:2S9ZZM9Q9V

object_name: pineoblastoma


subject: UNII:2S9ZZM9Q9V

object_name: adult pineoblastoma


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:90881

object_name: Childhood Central Nervous System Neoplasm


subject: CHEBI:90881


subject: CHEBI:90881

object_name: central nervous system cancer


subject: CHEBI:90881

object_name: Malignant neoplasm of the central nervous system


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: MESH:D056692

subject_name: Prebiotics

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C2703114

object_name: Solid Neoplasm


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Advanced Malignant Solid Neoplasm


subject: GTOPDB:12347

subject_name: penpulimab


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: UMLS:C4723695


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: cardiovascular disorder


subject: CHEBI:70746

object_name: chronic kidney disease


subject: CHEBI:70746

object_name: Chronic uremia


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:6015

subject_name: Isoflurane

object_name: aortic valve insufficiency


subject: CHEBI:6015

object_name: mitral valve insufficiency


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:139072

object_name: malignant endocrine neoplasm


subject: CHEBI:139072

object_name: Carcinoma of Endocrine Gland


subject: CHEBI:139072

object_name: Stage IV Bone Sarcoma AJCC v7


subject: CHEBI:139072

object_name: Lymphoma stage IV


subject: CHEBI:139072

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:139072

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:139072

object_name: metastatic melanoma


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: UMLS:C2984517

subject_name: Saponin-based Immunoadjuvant OBI-821

object_name: Childhood Neuroblastoma


subject: UMLS:C2984517

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:688561

subject_name: Procaterol

object_name: asthma


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN

object_name: gram-positive bacterial infections


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:9421

subject_name: Tazobactam


subject: PUBCHEM.COMPOUND:66550324

subject_name: Miricorilant

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:311Y5GV21M


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Hemolysis


subject: CHEBI:192614

object_name: Hemolysis - observation


subject: CHEBI:192614

object_name: Hemolysis, CTCAE


subject: CHEBI:192614

object_name: Blood Clot


subject: CHEBI:192614

object_name: thrombosis


subject: CHEBI:192614

object_name: Thrombosis of blood vessel


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: CHEBI:183660


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:41423

subject_name: Celecoxib

object_name: facial pain


subject: CHEBI:41423

object_name: Facial Pain, CTCAE


subject: CHEBI:6931

subject_name: Midazolam

object_name: tuberculosis


subject: CHEBI:71025

subject_name: ulipristal

object_name: endometriosis


subject: UMLS:C5198279

subject_name: AMG 557

object_name: EXCESS LMW-DNA


subject: UMLS:C5198279

object_name: lupus vulgaris


subject: UMLS:C5198279

object_name: lupus erythematosus


subject: UMLS:C5198279

object_name: discoid lupus erythematosus


subject: UMLS:C5198279

object_name: lupus cutaneous


subject: UNII:73SM5SF3OR

subject_name: Abrocitinib

object_name: toxic epidermal necrolysis


subject: UNII:73SM5SF3OR

object_name: Toxic Epidermal Necrolysis, CTCAE


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEBI:71200


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Incipient Schizophrenia


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: laryngectomy; status


subject: UMLS:C5203412

subject_name: Midazolam Liquid Injection


subject: CHEBI:6931


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: mild neurocognitive disorder


subject: CHEBI:70746

object_name: mild cognitive impairment


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: UNII:1FQ2RY5YHH

subject_name: Patiromer

object_name: end stage renal failure


subject: UNII:1FQ2RY5YHH

object_name: Chronic uremia


subject: UMLS:C4055175

subject_name: Curcumin-based Gel

object_name: periodontitis


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: dentin sensitivity


subject: CHEBI:33379

subject_name: erbium


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: PR:000007204

subject_name: estrogen receptor


subject: CHEBI:157802

subject_name: Cys-Arg


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:49544

subject_name: Chromic cation


subject: PR:000004968

subject_name: calretinin


subject: PR:000006466

subject_name: dehydrogenase/reductase SDR family member 4


subject: PR:000025662

subject_name: complement decay-accelerating factor


subject: UniProtKB:Q8VHX2

subject_name: EDAD_MOUSE Ectodysplasin-A receptor-associated adapter protein (sprot)


subject: PR:000006889

subject_name: ectodysplasin-A receptor-associated adapter protein


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Opioid intoxication


subject: UMLS:C5203254

subject_name: Rituximab Liquid Injection

object_name: myocardial infarction


subject: UMLS:C5203254

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C5203254

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C5203254

object_name: Inflammation


subject: UMLS:C5203254

object_name: myocardial ischemia


subject: UMLS:C5203254

object_name: Family history of ischemic heart disease


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: CHEBI:35480

subject_name: analgesic

object_name: pain agnosia


subject: CHEBI:35480

object_name: Pain insensitivity


subject: UMLS:C4722089

subject_name: Analgesics [TC]


subject: UMLS:C4722089


subject: UMLS:C0242937

subject_name: Analgesics, Non-Narcotic


subject: UMLS:C0242937


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: neonatal sepsis


subject: CHEBI:89324

object_name: Bacterial sepsis of newborn


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:139072

object_name: amphetamine abuse


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:5523

subject_name: Goserelin

object_name: Locally advanced breast cancer


subject: CHEBI:5523

object_name: luminal B breast carcinoma


subject: CHEBI:5523

object_name: luminal A breast carcinoma


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEMBL.COMPOUND:CHEMBL4297858

subject_name: BUDIGALIMAB

object_name: urothelial carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297858

object_name: transitional cell carcinoma


subject: UMLS:C4527193


subject: UMLS:C4527193


subject: GTOPDB:11762

subject_name: livmoniplimab


subject: GTOPDB:11762


subject: UNII:42SH7JCD82

subject_name: LIVMONIPLIMAB


subject: UNII:42SH7JCD82


subject: UMLS:C5237368

subject_name: ARGX 115


subject: UMLS:C5237368


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Childhood Solid Neoplasm


subject: UNII:8M7YSN2KII

object_name: Adult Solid Neoplasm


subject: UNII:8M7YSN2KII

object_name: Solid Neoplasm


subject: UNII:8M7YSN2KII

object_name: Neck Carcinoma


subject: UNII:8M7YSN2KII

object_name: head and neck neoplasm


subject: UNII:8M7YSN2KII

object_name: head and neck cancer


subject: UNII:8M7YSN2KII

object_name: non-small cell lung carcinoma


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII

object_name: nonpapillary renal cell carcinoma


subject: UNII:8M7YSN2KII

object_name: clear cell renal carcinoma


subject: UNII:8M7YSN2KII

object_name: renal cell adenocarcinoma


subject: UNII:8M7YSN2KII

object_name: renal cell carcinoma


subject: UNII:8M7YSN2KII

object_name: melanoma


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UNII:MQ5GV2WUK4

subject_name: LERAPOLTUREV

object_name: glioblastoma


subject: UNII:MQ5GV2WUK4

object_name: Childhood Glioblastoma


subject: UNII:MQ5GV2WUK4

object_name: adult glioblastoma


subject: UNII:MQ5GV2WUK4

object_name: Recurrent Childhood Glioblastoma


subject: UNII:MQ5GV2WUK4

object_name: Recurrent Glioblastoma


subject: UNII:MQ5GV2WUK4

object_name: Supratentorial Glioblastoma


subject: UNII:MQ5GV2WUK4

object_name: brain neoplasm


subject: CHEBI:7465

subject_name: Naltrexone

object_name: prostate carcinoma


subject: CHEBI:7465

object_name: prostate cancer


subject: CHEBI:7465

object_name: renal carcinoma


subject: CHEBI:7465

object_name: kidney cancer


subject: CHEBI:7465


subject: PR:000004692

subject_name: Bcl-2-related protein A1

object_name: obstructive sleep apnea syndrome


subject: CHEBI:51707

subject_name: diboron


subject: UMLS:C1521896

subject_name: Monoclonal Antibody B3


subject: UMLS:C2826153

object_name: metastatic melanoma


subject: UMLS:C0003250

subject_name: Monoclonal Antibodies


subject: UMLS:C5203232

subject_name: Monoclonal Antibody [EPC]


subject: UMLS:C0022260

subject_name: Isotonic Solutions

object_name: Post-Operative Pain


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: T-cell lymphoma stage IV


subject: CHEBI:4026

object_name: Stage IV Nasopharyngeal Carcinoma


subject: CHEBI:4026

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v7


subject: CHEBI:4026

object_name: Gastric carcinoma stage IV


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Stage IV Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Stage IV Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:214

subject_name: Prostavasin

object_name: Non-occlusive mesenteric ischemia


subject: CHEBI:15544

subject_name: Alprostadil


subject: CHEBI:131389

subject_name: magnesium citrate

object_name: Hypomagnesemia


subject: CHEBI:131389

object_name: Hypomagnesemia, CTCAE


subject: CHEBI:131391


subject: CHEBI:131391


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide


subject: UNII:3A3U0GI71G


subject: CHEBI:31794

subject_name: magnesium oxide


subject: CHEBI:31794


subject: CHEBI:15355

subject_name: Acetylcholine

object_name: hyperlipidemia


subject: CHEBI:15355

object_name: hyperlipoproteinemia


subject: CHEBI:15355

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:15355

object_name: Serum lipids high (finding)


subject: PUBCHEM.COMPOUND:6026

subject_name: Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg


subject: PUBCHEM.COMPOUND:6026


subject: PUBCHEM.COMPOUND:6026


subject: PUBCHEM.COMPOUND:6026


subject: CHEBI:3165

subject_name: Bradykinin


subject: CHEBI:3165


subject: CHEBI:3165


subject: CHEBI:3165


subject: CHEBI:132988


subject: CHEBI:132988


subject: CHEBI:132988


subject: CHEBI:132988


subject: UNII:S8TIM42R2W

subject_name: BRADYKININ


subject: UNII:S8TIM42R2W


subject: UNII:S8TIM42R2W


subject: UNII:S8TIM42R2W


subject: UMLS:C0006100


subject: UMLS:C0006100


subject: UMLS:C0006100


subject: UMLS:C0006100


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED


subject: UMLS:C0812735


subject: UMLS:C0812735


subject: UMLS:C0812735


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:124959

subject_name: Tilarginine


subject: CHEBI:124959


subject: CHEBI:124959


subject: CHEBI:124959


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:29321

subject_name: sodium nitroprusside


subject: CHEBI:29321


subject: CHEBI:29321


subject: CHEBI:29321


subject: UNII:EAO03PE1TC

subject_name: Sodium nitroprusside hydrate


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: CHEBI:44296

subject_name: TETRYLAMMONIUM


subject: CHEBI:44296


subject: CHEBI:44296


subject: CHEBI:44296


subject: MESH:D013662

subject_name: Tea


subject: MESH:D013662


subject: MESH:D013662


subject: MESH:D013662


subject: CHEBI:28621

subject_name: Trolamine


subject: CHEBI:28621


subject: CHEBI:28621


subject: CHEBI:28621


subject: CHEBI:35026

subject_name: triethylamine


subject: CHEBI:35026


subject: CHEBI:35026


subject: CHEBI:35026


subject: PR:000015198

subject_name: cationic amino acid transporter 2


subject: PR:000015198


subject: PR:000015198


subject: PR:000015198


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: stage IIIA rectal cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIC Rectal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIC Rectal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Rectal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Rectal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: stage IIB rectal cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Rectal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Rectal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: rectal signet ring cell adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: chronic gastritis


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Hand Injuries


subject: CHEBI:60802

subject_name: ropivacaine


subject: UMLS:C3836732

subject_name: intrathecal baclofen pump

object_name: cerebral palsy


subject: UNII:O9BP19HZ3Q

object_name: photosensitive epilepsy


subject: CHEBI:177298

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:177298

object_name: peritoneal carcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: UMLS:C5238233

subject_name: Wee1 Inhibitor ZN-c3

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C5238233

object_name: primary peritoneal carcinoma


subject: UMLS:C5238233


subject: UMLS:C5238233


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: non-small cell squamous lung carcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UMLS:C5706540

subject_name: Anti-CTLA-4 Monoclonal Antibody SHR-8068


subject: UMLS:C2347328

subject_name: sirolimus protein-bound particles

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C2347328

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C2347328

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage III renal cell cancer


subject: UMLS:C2347328

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C2347328

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2347328

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C2347328

object_name: Ovarian cancer stage IV


subject: UMLS:C2347328

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C2347328

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2347328

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2347328

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage IVA Bladder Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage IVA Bladder Cancer


subject: UMLS:C2347328

object_name: stage IVb bladder cancer


subject: UMLS:C2347328

object_name: Stage IVB Bladder Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: UMLS:C2347328

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C2347328

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C2347328

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C2347328

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage III Prostate Cancer AJCC v7


subject: UMLS:C2347328

object_name: Carcinoma of the prostate stage III


subject: UMLS:C2347328

object_name: Stage III Prostate Cancer AJCC v6


subject: UMLS:C2347328

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C2347328

object_name: Carcinoma breast stage IV


subject: UMLS:C2347328

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2347328

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2347328

object_name: Renal cell carcinoma recurrent


subject: UMLS:C2347328

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2347328

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C2347328

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C2347328

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2347328

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C2347328

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C2347328

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2347328

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2347328

object_name: Cervical carcinoma stage IVB


subject: UMLS:C2347328

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UMLS:C2347328

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UMLS:C2347328

object_name: Cervical carcinoma stage IVA


subject: UMLS:C2347328

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: UMLS:C2347328

object_name: Stage IIIA Cervical Cancer AJCC v6 and v7


subject: UMLS:C2347328

object_name: Stage IIIB Cervical Cancer AJCC v6 and v7


subject: UMLS:C2347328

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: UMLS:C2347328

object_name: cervical squamous cell carcinoma


subject: UMLS:C2347328

object_name: endometrial carcinoma


subject: UMLS:C2347328

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C2347328

object_name: Recurrent ovarian cancer


subject: UMLS:C2347328

object_name: Prostate cancer recurrent


subject: UMLS:C2347328

object_name: Bladder cancer recurrent


subject: UMLS:C2347328

object_name: Recurrent Malignant Neoplasm


subject: UMLS:C2347328

object_name: Cervix carcinoma recurrent


subject: UMLS:C2347328

object_name: Breast cancer recurrent


subject: UMLS:C2347328

object_name: uterine cancer


subject: GTOPDB:9596

subject_name: oleclumab

object_name: head and neck squamous cell carcinoma


subject: GTOPDB:9596

object_name: pancreatic ductal adenocarcinoma


subject: UNII:5CRY01URYQ

subject_name: OLECLUMAB


subject: UNII:5CRY01URYQ


subject: UMLS:C4085967

subject_name: Oleclumab


subject: UMLS:C4085967


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Birt-Hogg-Dube syndrome


subject: CHEBI:174806

subject_name: Nor-ketotifen

object_name: Atopic rhinitis


subject: CHEBI:174806

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:174806

object_name: Allergic rhinoconjunctivitis


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]

object_name: Deep Venous Thrombosis Related to COVID-19


subject: CHEBI:139554

subject_name: magnetic nanoparticle

object_name: anemia


subject: CHEBI:139554

object_name: Anemia, CTCAE


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Plasma cell myeloma refractory


subject: UNII:I031V2H011

object_name: Plasma cell myeloma recurrent


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Chronic low back pain


subject: PUBCHEM.COMPOUND:66563688

object_name: malaria


subject: CHEBI:75551


subject: CHEBI:139388

subject_name: Temurin

object_name: Caffeine-related disorder


subject: CHEBI:139388

object_name: Cognitive changes


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:6801

subject_name: Metformin

object_name: neoplasm


subject: UMLS:C2347328

object_name: pulmonary hypertension


subject: UMLS:C2347328

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:71940

object_name: Fatigue


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Pulmonary Diffusing Capacity


subject: CHEBI:17245

subject_name: Carbon monoxide


subject: UMLS:C2752105

subject_name: helium homeopathic preparation


subject: CHEBI:30217

subject_name: Helium


subject: CHEBI:5938

subject_name: Interferon beta-1b

object_name: cardiomyopathy


subject: CHEBI:5938

object_name: heart disorder


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: prostate carcinoma


subject: UNII:KXG2PJ551I

object_name: prostate cancer


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: Bladder cancer stage IV


subject: MESH:D015314

subject_name: Dialysis Solutions

object_name: Inflammation


subject: MESH:D015314

object_name: Chronic uremia


subject: UMLS:C0011947


subject: UMLS:C0011947


subject: PUBCHEM.COMPOUND:2269

object_name: Azithromycin adverse reaction


subject: PUBCHEM.COMPOUND:2269

object_name: long QT syndrome


subject: PUBCHEM.COMPOUND:2269

object_name: familial long QT syndrome


subject: PUBCHEM.COMPOUND:2269

object_name: Prolonged QT interval


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: adult liposarcoma


subject: CHEBI:231005

object_name: liposarcoma


subject: CHEBI:231005

object_name: pediatric liposarcoma


subject: CHEBI:231005

object_name: undifferentiated pleomorphic sarcoma


subject: CHEBI:231005

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:231005

object_name: leiomyosarcoma


subject: CHEBI:231005

object_name: Childhood Leiomyosarcoma


subject: CHEBI:231005

object_name: Adult Leiomyosarcoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: impotence


subject: CHEBI:3160

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:3160

object_name: Erectile dysfunction


subject: CHEBI:3160

object_name: sexual disorder


subject: CHEBI:3160

object_name: physiological sexual disorder


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: hypoplastic left heart syndrome


subject: CHEBI:38290

object_name: tricuspid atresia


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: PUBCHEM.COMPOUND:86764103

object_name: Parkinson disease


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine

object_name: Myelodysplasia


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: metastatic colorectal cancer


subject: CHEBI:3638

subject_name: Chloroquine

object_name: Anemia in children


subject: UMLS:C4310591

object_name: Enterobacteriaceae Infections


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Upper Respiratory Infections


subject: CHEBI:89324

object_name: Recurrent upper respiratory tract infections


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Renal Pelvis and Ureter Carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: PUBCHEM.COMPOUND:4895

subject_name: Pred Forte

object_name: preretinal fibrosis


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEMBL.COMPOUND:CHEMBL1187846

subject_name: SCOPOLAMINE

object_name: Seizure Related to COVID-19


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: epilepsy


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: visual epilepsy


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: Memory Disorders


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: mild neurocognitive disorder


subject: KEGG.COMPOUND:C01851

subject_name: Scopolamine


subject: KEGG.COMPOUND:C01851


subject: KEGG.COMPOUND:C01851


subject: KEGG.COMPOUND:C01851


subject: KEGG.COMPOUND:C01851


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: UMLS:C5392723


subject: UMLS:C5392723

object_name: mild cognitive impairment


subject: UNII:6C9UKZ0CYE

object_name: kidney failure


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Klatskin Tumor


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: Partial thickness burn


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Acquired esotropia


subject: CHEBI:601027

subject_name: Aliskiren

object_name: vitamin D deficiency


subject: UNII:JTZ51LIXN4

subject_name: NEMTABRUTINIB

object_name: diffuse large B-cell lymphoma


subject: UNII:JTZ51LIXN4

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:JTZ51LIXN4

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:JTZ51LIXN4

object_name: Richter syndrome


subject: DRUGBANK:DB18866

subject_name: Nemtabrutinib


subject: DRUGBANK:DB18866


subject: DRUGBANK:DB18866


subject: DRUGBANK:DB18866


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:4975

subject_name: Famotidine

object_name: dyskinesia of esophagus


subject: CHEBI:4975

object_name: aspiration pneumonia


subject: CHEBI:4975

object_name: aspiration pneumonitis


subject: CHEBI:4975

object_name: Gastric motor function disorder


subject: CHEBI:135552

subject_name: Prucalopride


subject: CHEBI:135552

object_name: Heartburn


subject: CHEBI:135552


subject: CHEBI:135552


subject: CHEBI:135552


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: Anhedonia


subject: CHEBI:89981

subject_name: Endotoxins


subject: UMLS:C3536985

subject_name: gimeracil + oteracil potassium + tegafur

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Urinary incontinence


subject: CHEBI:192614

object_name: Urinary Incontinence, CTCAE 5.0


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: GTOPDB:11827

subject_name: telitacicept

object_name: diffuse cutaneous systemic sclerosis


subject: GTOPDB:11827

object_name: diffuse scleroderma


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: CHEMBL.COMPOUND:CHEMBL5095293


subject: UMLS:C5238006


subject: UMLS:C5238006


subject: CHEBI:31859

subject_name: Modafinil

object_name: Shift-Work Sleep Disorder


subject: CHEBI:77590

subject_name: Armodafinil


subject: CHEBI:64816

object_name: Metastatic Kidney Medullary Carcinoma


subject: CHEBI:64816

object_name: SMARCB1 Negative


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:175901


subject: CHEBI:90942

subject_name: Ixazomib


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:90942


subject: UMLS:C5201181

subject_name: H.P. acthar gel

object_name: nephrotic syndrome


subject: UMLS:C5201181

object_name: Nephrotic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:71308244

subject_name: Naldemedine

object_name: acute pancreatitis


subject: CHEBI:35498

subject_name: diuretic

object_name: obstructive sleep apnea syndrome


subject: UMLS:C0012798

subject_name: Diuretics


subject: CHEBI:68584

subject_name: Ezogabine

object_name: endogenous depression


subject: CHEBI:68584

object_name: major depressive disorder


subject: CHEBI:68584

object_name: Cancer patients and suicide and depression


subject: CHEBI:68584

object_name: Depressed - symptom


subject: CHEBI:68584

object_name: Depression, CTCAE


subject: CHEBI:137359

object_name: cerebral palsy


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:7903

subject_name: Pamidronic acid

object_name: plasma cell myeloma


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Pancreas carcinoma resectable


subject: MESH:C000627770

subject_name: folfirinox


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: diarrhea


subject: CHEBI:29007

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:29007

object_name: Diarrhea, CTCAE


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Refractory drug response


subject: UNII:PQX0D8J21J

object_name: RAS-RAF Pathway Deregulation


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Osteochondritis


subject: CHEBI:38290

object_name: Compulsion


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: Atypical behavior


subject: CHEBI:60802

subject_name: ropivacaine

object_name: digestive system disorder


subject: CHEBI:60802

object_name: gastrointestinal disease


subject: UMLS:C5854520

subject_name: ROS1/TRK/ALK Inhibitor TY-2136b

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5854520

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UNII:5Y869C2THE

object_name: rheumatoid arthritis


subject: MESH:C469818


subject: CHEBI:167204

subject_name: Mosapride

object_name: Foreign object accidentally left in body during endoscopic examination


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: hepatobiliary disorder


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: benign prostatic hyperplasia


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C3252280

object_name: inherited lipid metabolism disorder


subject: UMLS:C3252280

object_name: Dyslipidemia


subject: UNII:WP6PY72ZH3

subject_name: Motolimod

object_name: adult lymphoma


subject: UNII:WP6PY72ZH3

object_name: lymphoma


subject: UNII:WP6PY72ZH3

object_name: pediatric lymphoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Locally Advanced Gastric Adenocarcinoma


subject: MESH:C586502

subject_name: tegafur-gimeracil-oteracil

object_name: Effects of chemotherapy


subject: MESH:C586502


subject: CHEBI:49603

subject_name: Lapatinib

object_name: melanoma


subject: UMLS:C5391556

object_name: Childhood Neuroblastoma


subject: UMLS:C5391556

object_name: neuroblastoma


subject: UMLS:C5391556

object_name: Refractory Neuroblastoma


subject: UMLS:C5391556

object_name: Neuroblastoma recurrent


subject: UMLS:C5419110

subject_name: Cu-67 sartate


subject: UMLS:C5419110


subject: UMLS:C5419110


subject: UMLS:C5419110


subject: CHEBI:35498

subject_name: diuretic

object_name: endolymphatic hydrops


subject: CHEBI:35498

object_name: eustachian tube disorder


subject: UMLS:C0012798

subject_name: Diuretics


subject: UMLS:C0012798


subject: UMLS:C5399719

subject_name: Diuretic [APC]


subject: UMLS:C5399719


subject: CHEBI:94366

subject_name: itraconazole

object_name: bronchiectasis


subject: CHEBI:94366

object_name: Adult bronchiectasis


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: retinopathy of prematurity


subject: CHEBI:46195

object_name: exudative vitreoretinopathy 1


subject: CHEBI:46195

object_name: Retinopathy of Prematurity, AE


subject: CHEBI:32133

object_name: aortic dissection


subject: CHEBI:32133

object_name: Aortic dissection


subject: CHEBI:32133

object_name: Acute lung injury/Acute respiratory distress syndrome (ARDS)


subject: UNII:0CLL4232KD

subject_name: SIVELESTAT SODIUM


subject: UNII:0CLL4232KD


subject: UNII:0CLL4232KD


subject: UMLS:C2699305

subject_name: Sivelestat Sodium


subject: UMLS:C2699305


subject: UMLS:C2699305


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: pervasive developmental disorder


subject: PUBCHEM.COMPOUND:135402009

object_name: autism


subject: PUBCHEM.COMPOUND:135402009

object_name: autism spectrum disorder


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Sedation


subject: CHEBI:73604

object_name: Sedated


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Mild Traumatic Brain Injury


subject: UMLS:C5907993

subject_name: CTPS1 Inhibitor STP938

object_name: Childhood Solid Neoplasm


subject: UMLS:C5907993

object_name: Adult Solid Neoplasm


subject: UMLS:C5907993

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: Heart failure with reduced ejection fraction


subject: PR:000009978

subject_name: lactotransferrin


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: CHEBI:41948

subject_name: Eflornithine

object_name: Hirsutism, CTCAE


subject: UMLS:C0282042

object_name: Hirsutism


subject: UMLS:C0282042


subject: CHEBI:31355

subject_name: Carboplatin

object_name: small intestine lymphoma


subject: CHEBI:31355

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:31355

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:41879

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:41879

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:41879

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:41879

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:41879

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:41879

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:41879

object_name: testicular lymphoma


subject: CHEBI:41879

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:41879

object_name: intraocular lymphoma


subject: CHEBI:41879

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:41879

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:41879

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:41879


subject: CHEBI:41879

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:41879

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:41879

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:41879

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:41879

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:41879

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:83766

subject_name: Olaparib

object_name: Advanced Bladder Carcinoma


subject: CHEBI:83766

object_name: Bladder cancer stage IV


subject: CHEBI:83766

object_name: Metastatic Genitourinary System Carcinoma


subject: CHEBI:83766

object_name: Advanced Genitourinary System Carcinoma


subject: CHEBI:83766

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C0677882

subject_name: DepoCyt

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:3213

subject_name: Bumetanide

object_name: type 2 diabetes mellitus


subject: CHEBI:6121

subject_name: Ketamine

object_name: Acute Ischemic Stroke


subject: CHEBI:6121

object_name: Ischemic stroke


subject: CHEBI:145499

subject_name: Donepezil

object_name: Memory Disorders


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:85994

object_name: uterine carcinosarcoma


subject: CHEMBL.COMPOUND:CHEMBL2109450

object_name: discoid lupus erythematosus


subject: CHEMBL.COMPOUND:CHEMBL2109450

object_name: EXCESS LMW-DNA


subject: CHEMBL.COMPOUND:CHEMBL2109450

object_name: lupus vulgaris


subject: CHEMBL.COMPOUND:CHEMBL2109450

object_name: lupus erythematosus


subject: CHEMBL.COMPOUND:CHEMBL2109450

object_name: lupus cutaneous


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: anticoagulants; increased


subject: CHEBI:9332

subject_name: Sulfamethoxazole

object_name: hypotonia-cystinuria syndrome


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: primary brain neoplasm


subject: CHEBI:231005

object_name: brain cancer


subject: CHEBI:231005

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:43689

subject_name: isopentylamine

object_name: liver carcinoma


subject: CHEBI:132922

object_name: Ureteral spasm


subject: CHEBI:132922


subject: CHEBI:132922

object_name: ureteropelvic junction obstruction


subject: CHEBI:132922

object_name: Ureteropelvic junction obstruction


subject: CHEBI:132922

object_name: Disorder of urinary stent


subject: CHEBI:132922

object_name: urolithiasis


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Carcinoma liver resectable


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:85994


subject: UMLS:C0083104

subject_name: juzentaihoto

object_name: breast carcinoma


subject: CHEBI:132922

object_name: Knee arthropathy


subject: CHEBI:132922

object_name: Hip arthropathy


subject: CHEBI:132922

object_name: Safety Issues


subject: CHEBI:132922

object_name: Postoperative Complications


subject: CHEBI:132922

object_name: Analgesic adverse reaction


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: Metastatic cholangiocarcinoma


subject: UNII:Y6BX7BL23K

object_name: Cholangiocarcinoma non-resectable


subject: CHEBI:174615

object_name: osteogenesis imperfecta


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UMLS:C1509490

subject_name: green tea leaf extract decaffeinated

object_name: Prediabetes


subject: UNII:K424WH3WU0

subject_name: TROTABRESIB


subject: UNII:K424WH3WU0

object_name: neoplastic meningitis


subject: UNII:K424WH3WU0

object_name: metastatic malignant neoplasm in the brain


subject: DRUGBANK:DB17421

subject_name: Trotabresib


subject: DRUGBANK:DB17421


subject: DRUGBANK:DB17421


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Postoperative Pain, Acute


subject: CHEBI:42797

subject_name: Gabapentin


subject: UNII:2498M8N65F

subject_name: DPC 083

object_name: HIV infection


subject: CHEBI:231347

subject_name: Triapine

object_name: endometrial serous adenocarcinoma


subject: PUBCHEM.COMPOUND:2269

object_name: Comorbidities and coexisting conditions


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:135117

subject_name: ftivazide

object_name: Severe Acute Malnutrition


subject: CHEBI:135117

object_name: Child Malnutrition


subject: CHEBI:135117


subject: CHEBI:6030

subject_name: Isoniazid


subject: CHEBI:6030


subject: CHEBI:6030


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: CHEBI:27306


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: UMLS:C5667057

subject_name: Cafelkibart

object_name: triple-negative breast carcinoma


subject: CHEBI:131902

object_name: complex regional pain syndrome


subject: CHEBI:38940

subject_name: Sunitinib

object_name: liver cancer


subject: CHEBI:38940

object_name: Adult Liver Carcinoma


subject: DRUGBANK:DB19449

object_name: hematopoietic and lymphoid cell neoplasm


subject: DRUGBANK:DB19449

object_name: hematopoietic and lymphoid system neoplasm


subject: DRUGBANK:DB19449

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: plasma cell myeloma


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UNII:8A5G600D9V

subject_name: NORUCHOLIC ACID

object_name: sclerosing cholangitis


subject: UNII:8A5G600D9V

object_name: primary sclerosing cholangitis


subject: CHEBI:131174

subject_name: Navitoclax


subject: CHEBI:131174

object_name: non-Hodgkin lymphoma


subject: UMLS:C1831992

subject_name: ABT 263


subject: UMLS:C1831992


subject: UMLS:C0030956

subject_name: Peptides

object_name: melanoma


subject: CHEBI:9907

subject_name: ursodiol

object_name: cystic fibrosis


subject: CHEBI:9907

object_name: digestive system disorder


subject: UMLS:C5787245

subject_name: ADC SO-N102

object_name: pancreatic neoplasm


subject: UMLS:C5787245

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5787245

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297772

object_name: severe sepsis with septic shock


subject: CHEBI:47136

subject_name: pentachlorobenzene

object_name: triple-negative breast carcinoma


subject: CHEBI:82160

subject_name: Fenson


subject: CHEBI:53156

subject_name: polychlorobiphenyl


subject: CHEBI:71417

subject_name: Procarbazine


subject: UMLS:C5196682

object_name: respiratory system disorder


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen


subject: CHEBI:52603


subject: GTOPDB:5019

subject_name: LPS


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: UMLS:C5666944

object_name: Adult Solid Neoplasm


subject: UMLS:C5666944

object_name: Biliary cancer metastatic


subject: UMLS:C5666944

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5666944

object_name: ovarian serous cystadenocarcinoma


subject: UMLS:C5666944

object_name: ovarian serous adenocarcinoma


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Thermal burn


subject: CHEBI:59495

subject_name: CIDOFOVIR

object_name: recurrent respiratory papillomatosis


subject: CHEBI:530615


subject: CHEBI:134514


subject: CHEBI:3696

subject_name: Cidofovir


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Hip arthropathy


subject: DRUGBANK:DB21750

subject_name: Volenrelaxin

object_name: chronic kidney disease


subject: DRUGBANK:DB21750

object_name: Chronic Kidney Disease, CTCAE


subject: PUBCHEM.COMPOUND:75492608

subject_name: Coco diethanolamide

object_name: Pediculus humanus capitis infestation


subject: PUBCHEM.COMPOUND:75492608

object_name: Pediculosis


subject: CHEBI:125535

subject_name: Esreboxetine

object_name: hypersomnia


subject: CHEBI:125535

object_name: narcolepsy-cataplexy syndrome


subject: CHEBI:135342

subject_name: Reboxetine


subject: CHEBI:135342


subject: PUBCHEM.COMPOUND:6323481

subject_name: phosphatidylserine

object_name: type 2 diabetes mellitus


subject: KEGG.COMPOUND:C02737

subject_name: Phosphatidylserine


subject: CHEBI:18303


subject: GTOPDB:1160

subject_name: hCG

object_name: Ovarian hyperstimulation


subject: GTOPDB:1160

object_name: Miscarriage


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: CHEBI:81570


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C0309130


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C1141639


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427

object_name: Pregnant


subject: CHEBI:6427


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist


subject: UMLS:C1518041


subject: UMLS:C1518041


subject: UMLS:C5814274

object_name: immunodeficiency disease


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Opioid withdrawal


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: Hyperactivity


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: type 1 diabetes mellitus


subject: CHEBI:5100

subject_name: Flucytosine

object_name: brain cancer


subject: CHEBI:5100

object_name: brain neoplasm


subject: CHEBI:5100

object_name: glioblastoma


subject: CHEBI:5100

object_name: Childhood Glioblastoma


subject: CHEBI:5100

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:89455219

subject_name: tirabrutinib

object_name: non-Hodgkin lymphoma


subject: CHEBI:7553

subject_name: Niclosamide

object_name: classic familial adenomatous polyposis


subject: CHEBI:7553

object_name: Adenomatous colonic polyposis


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Breast cancer stage II


subject: UNII:GKF8S4C432

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: Stage II Bladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:156963654

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C0074009

object_name: Metastatic osteosarcoma


subject: UNII:GQE1BJE2NI

subject_name: intetumumab

object_name: melanoma


subject: UMLS:C1881068


subject: UNII:OGN7X90BT8

subject_name: Lenabasum

object_name: diffuse cutaneous systemic sclerosis


subject: UNII:OGN7X90BT8

object_name: diffuse scleroderma


subject: UMLS:C5854073


subject: UMLS:C5854073


subject: CHEBI:135901

subject_name: lanreotide

object_name: autosomal dominant polycystic kidney disease


subject: UMLS:C0051846

subject_name: angiopeptin


subject: UNII:Q0656F336Y

object_name: bronchiectasis


subject: UMLS:C5907983

subject_name: CK1 Alpha Degrader GLB-001

object_name: essential thrombocythemia


subject: UMLS:C5907983

object_name: acquired polycythemia vera


subject: UMLS:C5907983

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5907983

object_name: acute myeloid leukemia


subject: UMLS:C5907983

object_name: Myelodysplasia


subject: UMLS:C5907983

object_name: myelofibrosis


subject: UMLS:C5907983

object_name: myeloid neoplasm


subject: CHEBI:6801

subject_name: Metformin

object_name: Females


subject: GTOPDB:13624

subject_name: inclisiran

object_name: myocardial ischemia


subject: GTOPDB:13624

object_name: Family history of ischemic heart disease


subject: CHEBI:2705

subject_name: Anatabine

object_name: Inflammation


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: psoriasis vulgaris


subject: UMLS:C0378942


subject: PUBCHEM.COMPOUND:9916099

subject_name: Letermovir

object_name: graft versus host disease


subject: CHEBI:143528

subject_name: DL-Arabinose

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:89NA02M4RX

subject_name: PECTIN


subject: CHEBI:17309

subject_name: pectin


subject: UMLS:C0036478

subject_name: SD Antigens

object_name: poliomyelitis


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: Axial Spondyloarthritis


subject: UMLS:C0540110

subject_name: HOE 901

object_name: maturity-onset diabetes of the young type 1


subject: UNII:JYW18Y92UP

object_name: myeloid leukemia


subject: CHEBI:567361

subject_name: Cladribine


subject: CHEBI:41977

subject_name: Daunorubicin


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: Primary bacterial peritonitis


subject: UMLS:C3540708

object_name: acute spontaneous bacterial peritonitis


subject: UMLS:C3540708

object_name: chronic liver failure


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: bile duct adenocarcinoma


subject: GTOPDB:12966

subject_name: cadonilimab


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:46058

subject_name: TAXOTERE

object_name: cancer


subject: CHEBI:46058

object_name: neoplasm


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: brain neoplasm


subject: CHEBI:95341

subject_name: Baricitinib

object_name: frontal fibrosing alopecia


subject: UNII:G1G66XE93W

object_name: Childhood Breast Carcinoma


subject: UNII:G1G66XE93W

object_name: breast carcinoma


subject: UNII:G1G66XE93W

object_name: breast cancer


subject: UNII:G1G66XE93W

object_name: Carcinoma breast stage IV


subject: UNII:G1G66XE93W

object_name: estrogen-receptor positive breast cancer


subject: UNII:G1G66XE93W

object_name: HER2 positive breast carcinoma


subject: CHEBI:23359

subject_name: colchicine

object_name: diarrhea


subject: CHEBI:23359

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:23359

object_name: Diarrhea, CTCAE


subject: UMLS:C0599934

subject_name: Vaccines, Peptide

object_name: prostate carcinoma


subject: UMLS:C0599934

object_name: prostate cancer


subject: UNII:DTZ9PEC9JL

subject_name: Diammonium succinate

object_name: Menopause related conditions


subject: UMLS:C0103090

subject_name: Ammonium Succinate


subject: CHEBI:15741

subject_name: Succinic acid


subject: UMLS:C4722471

object_name: mucosal melanoma


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Chronic liver disease


subject: PUBCHEM.COMPOUND:135449332

object_name: liver disorder


subject: PUBCHEM.COMPOUND:135449332

object_name: hepatitis B


subject: PUBCHEM.COMPOUND:135449332


subject: PUBCHEM.COMPOUND:135449332

object_name: HIV infection


subject: CHEBI:31858

subject_name: Mizoribine

object_name: nephrotic syndrome


subject: CHEBI:31858

object_name: Nephrotic Syndrome, CTCAE


subject: UMLS:C1579319

subject_name: pneumococcal conjugate vaccine

object_name: Pneumonia in children


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Tooth Wear


subject: CHEMBL.COMPOUND:CHEMBL4802185

subject_name: MAPLIRPACEPT

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Refractory Intravascular Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: High grade B-cell lymphoma refractory


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Recurrent Intravascular Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: High grade B-cell lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Refractory Grade 3b Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: B-cell lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Recurrent Gray-Zone Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: UMLS:C4725956

subject_name: SIRPa-IgG4 Fc

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4725956

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4725956

object_name: Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UMLS:C4725956

object_name: Refractory Intravascular Large B-Cell Lymphoma


subject: UMLS:C4725956

object_name: Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4725956

object_name: Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4725956

object_name: High grade B-cell lymphoma refractory


subject: UMLS:C4725956

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UMLS:C4725956

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UMLS:C4725956

object_name: Recurrent Intravascular Large B-Cell Lymphoma


subject: UMLS:C4725956

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UMLS:C4725956

object_name: Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UMLS:C4725956

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UMLS:C4725956

object_name: High grade B-cell lymphoma recurrent


subject: UMLS:C4725956

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UMLS:C4725956

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4725956

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4725956

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: UMLS:C4725956

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UMLS:C4725956

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UMLS:C4725956

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UMLS:C4725956

object_name: Refractory Grade 3b Follicular Lymphoma


subject: UMLS:C4725956

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UMLS:C4725956

object_name: B-cell lymphoma recurrent


subject: UMLS:C4725956

object_name: Recurrent Gray-Zone Lymphoma


subject: UMLS:C4725956

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: GTOPDB:12036

subject_name: ontorpacept

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: GTOPDB:12036

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: GTOPDB:12036

object_name: Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: GTOPDB:12036

object_name: Refractory Intravascular Large B-Cell Lymphoma


subject: GTOPDB:12036

object_name: Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: GTOPDB:12036

object_name: Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: GTOPDB:12036

object_name: High grade B-cell lymphoma refractory


subject: GTOPDB:12036

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: GTOPDB:12036

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: GTOPDB:12036

object_name: Recurrent Intravascular Large B-Cell Lymphoma


subject: GTOPDB:12036

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: GTOPDB:12036

object_name: Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: GTOPDB:12036

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: GTOPDB:12036

object_name: High grade B-cell lymphoma recurrent


subject: GTOPDB:12036

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: GTOPDB:12036

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: GTOPDB:12036

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: GTOPDB:12036

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: GTOPDB:12036

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: GTOPDB:12036

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: GTOPDB:12036

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: GTOPDB:12036

object_name: Refractory Grade 3b Follicular Lymphoma


subject: GTOPDB:12036

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: GTOPDB:12036

object_name: B-cell lymphoma recurrent


subject: GTOPDB:12036

object_name: Recurrent Gray-Zone Lymphoma


subject: GTOPDB:12036

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314996

subject_name: ONTORPACEPT

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Refractory Intravascular Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: High grade B-cell lymphoma refractory


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Recurrent Intravascular Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: High grade B-cell lymphoma recurrent